Table 1.
Genes associated with muscular dystrophies
Disease | Inheritance | Gene | Protein | References |
DMD, Becker muscular dystrophy | XR | DMD | Dystrophin | Monaco et al., 1986; Burghes et al., 1987 |
Emery-Dreifuss muscular dystrophy | XR | EMD | Emerin | Bione et al., 1994; |
XR | FHL1 | Four and a half LIM domains 1 | Gueneau et al., 2009 | |
AD/AR | LMNA | Lamin A/C | Bonne et al., 1999 | |
LGMD1A | AD | MYOT | Myotilin | Hauser et al., 2000 |
LGMD1B | AD | LMNA | Lamin A/C | Muchir et al., 2000 |
LGMD1C | AD | CAV3 | Caveolin-3 | Minetti et al., 1998 |
LGMD1D | AD | DES | Desmin | Greenberg et al., 2012 |
LGMD1E | AD | DNAJB6 | DnaJ (Hsp40) homolog, subfamily B, member 6 | Sarparanta et al., 2012 |
LGMD2A | AR | CAPN3 | Calpain 3 | Richard et al., 1995 |
LGMD2B, Miyoshi myopathy, distal anterior compartment myopathy | AR | DYSF | Dysferlin | Bashir et al., 1998; Liu et al., 1998 |
LGMD2C | AR | SGCG | γ-Sarcoglycan | Noguchi et al., 1995 |
LGMD2D | AR | SGCA | α-Sarcoglycan | Roberds et al., 1994 |
LGMD2E | AR | SGCB | β-Sarcoglycan | Bönnemann et al., 1995; Lim et al., 1995 |
LGMD2F | AR | SGCD | δ-Sarcoglycan | Nigro et al., 1996 |
LGMD2G | AR | TCAP | Titin-cap | Moreira et al., 2000 |
LGMD2H | AR | TRIM32 | Tripartite motif containing 32 | Frosk et al., 2002 |
LGMD2J | AR | TTN | Titin | Hackman et al., 2002 |
Tibial MD | AD | |||
LGMD2L | AR | ANO5 | Anoctamin 5 | Bolduc et al., 2010 |
LGMD2Q | AR | PLEC | Plectin | Gundesli et al., 2010 |
MDDGA1, MDDGC1 (LGMD2K)a | AR | POMT1 | Protein-O-mannosyltransferase 1 | Beltrán-Valero de Bernabe et al., 2002 |
MDDGA2, MDDGC2 (LGMD2N) | AR | POMT2 | Protein-O-mannosyltransferase 2 | van Reeuwijk et al., 2005 |
MDDGA3, MDDGC3 (LGMD2O) | AR | POMGNT1 | Protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase | Yoshida et al., 2001 |
MDDGA4, MDDGC4 (LGMD2M) | AR | FKTN | Fukutin | Kobayashi et al., 1998 |
MDDGA5, MDDGC5 (LGMD2I) | AR | FKRP | Fukutin related protein | Brockington et al., 2001 |
MDDGA6 | AR | LARGE | like-glycosyltransferase | Longman et al., 2003 |
MDDGA7 | AR | ISPD | Isoprenoid synthase domain containing | Roscioli et al., 2012; Willer et al., 2012 |
MDDGA8 | AR | GTDC2 | Glycosyltransferase-like domain containing 2 | Manzini et al., 2012 |
MDDGA | AR | B3GNT1 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1 | Buysse et al., 2013 |
MDDGA | AR | B3GALNT2 | β-1,3-N-acetylgalactosaminyltransferase 2 | Stevens et al., 2013 |
MDDGC9 (LGMD) | AR | DAG1 | Dystroglycan | Hara et al., 2011 |
DM1 | AD | DMPK | CTGexp in 3′ UTR | Brook et al., 1992; Fu et al., 1992; Mahadevan et al., 1992 |
DM2 | AD | CNBP | CCTGexp in intron 1 | Liquori et al., 2001 |
FSHD1 | AD | DUX4 | Double homeobox 4 | Kowaljow et al., 2007; Lemmers et al., 2010 |
FSHD2 | AD, Digenic | DUX4, SMCHD1 | Double homeobox 4, structural maintenance of chromosomes flexible hinge domain containing 1 | Lemmers et al., 2012 |
AD, autosomal dominant; AR, autosomal recessive; XR, X-linked recessive; LGMD, limb-girdle muscular dystrophy (LGMD1, autosomal dominant; LGMD2, autosomal recessive); MDDG, muscular dystrophy-dystroglycanopathy; DM, myotonic dystrophy; FSHD, facioscapulohumeral muscular dystrophy; exp, expansion.
Alternative or previous nomenclature is provided in parentheses.